drugset / Trial / NCT00200694

Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.

NCT00200694

Phase 4 Terminated 18 enrolled Nantes University Hospital
RandomizedCrossoverOpen-label

Summary

Determine the best strategy for proteinuria lowering in patients with proteinuria \> 1 g/day receiving ACEI and ARB combination: either increase of ACEI and ARB dosage or increase of diuretic dosage.

Timeline

Start
2005-03
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified
Subject Ramipril Small molecule 5 mg
Subject Ramipril Small molecule 10 mg
Subject Valsartan Small molecule 80 mg
Subject Valsartan Small molecule 160 mg

Indications